The in vitro antimicrobial activity of fruit and leaf crude extracts of Momordica charantia: A Tanzania medicinal plant

African Health Sciences

Volumn 9, Issue 1, 2009, Pages 34-39

  Mwambete, K D ^a  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

Antimicrobial activity; Momordica charantia; Petroleum ether and methanolic crude extracts

Indexed keywords

CLOTRIMAZOLE; GENTAMICIN; MOMORDICA CHARANTIA EXTRACT; ANTIINFECTIVE AGENT; METHANOL; PETROLEUM; PLANT EXTRACT;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CANDIDA ALBICANS; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DISK DIFFUSION; DRUG SCREENING; FRUIT; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MEDICINAL PLANT; MOMORDICA CHARANTIA; NONHUMAN; PLANT LEAF; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHI; STAPHYLOCOCCUS AUREUS; TANZANIA; BACTERIA; CHEMISTRY; DRUG EFFECTS; EVALUATION STUDY; FUNGUS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST;

ANTI-INFECTIVE AGENTS; BACTERIA; FRUIT; FUNGI; METHANOL; MICROBIAL SENSITIVITY TESTS; MOMORDICA CHARANTIA; PETROLEUM; PLANT EXTRACTS; PLANT LEAVES; PLANTS, MEDICINAL; TANZANIA;

EID: 77949344945     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. WHO-Global Principles for the Containment of Antimicrobial Resistance in Animals Intended for Food. Last update January 2008; Accessible at: www.who.int/emc/diseases/zoo/who-global-principles.html.
2. Okeke IN, Aboderin OA, Byarugaba DK, Ojo KK and Opintan JA. Growing Problem of Multidrug-Resistant Enteric Pathogens in Africa. Emerg Infect Dis. Perspective 2007;13 (11):393-96.
3. Ndugulile F, Jureen R, Harthug S, Urassa W and Langeland N. Extended Spectrum beta-Lactamases among Gramnegative bacteria of nosocomial origin from an Intensive Care Unit of a tertiary health facility in Tanzania. BMC Infect Dis 2005; 5(86): 2334-39.
4. Centre for diseases control (CDC). National Nosocomial Infections Surveillance System. Accessible at: www.cdc.gov/ncidod/dhqp/nnis.html. Last Updated May 05, 2006.
5. th Ed. Blackwell Publishing, 2004. Chapt. (13-14): 220-250.
6. rd Ed. McGraw Hill. Madrid. 2002. p. 21-25: 495-664.
7. Health Protection Agency. Infection with organisms carrying extended spectrum beta-lactamase in the community: First report. CDR Wkly. 2003; 13(32):3.
8. Sabir MS, Ahmad DS, Hussain IM, Tahir KM. Antibacterial activity of Elaeagnus umbellate (Thumb.) a medicinal plant from Pakstani. Saudi Med J., 2007; 28(2): 259-263.
9. Nagasawa H, Watanabe K, Inatomi H et al. "Effects of bitter melon (Momordica charantia) or ginger rhizome (Zingiber offifinale Rosc.) on spontaneous mammary tumorigenesis in SHN m ice." Am J Clin Med., 2002; 30(2-3): 195-205.
10. Taylor L. Technical report for Bitter lemon (Momordica charantia). In Herbal Secrets of the Rainforest, 2nd edition, Sage Press, Inc., 2002. p. 1-103.
11. National Bitter Melon Council. Better living through bitter melon. Bitter Melon and AIDS. Accessible at: http://www.bittermelon.org/pages/heal/research- aids.html
12. Grover JK, Yadav SP. Pharmacological actions and potential uses of Momordica charantia: A review. J Ethnopharmacol., 2004; 93: 123-132.
13. Ahmed I, Lakhani MS, Gillett M, et al. "Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (Karela) fruit extract in streptozotocin-induced diabetic rats." Diabetes Res Clin Pract., 2001; 51(3):155-61.
14. Takemoto DJ, Dunford C, Vaughn D, Kramer KJ, et al. Guanylate cyclase activity in human leukemic and normal lymphocytes. Enzyme inhibition and cytotoxicity of plant extracts. Enzyme, 1982; 27(3): 179-88.
15. Vikrant V, Grover JK, Tandon N, et al. "Treatment with extracts of Momordica charantia and Eugenia jambolana prevents hyperglycem ia and hyperinsulinem ia in fructose fed rats." J Ethnopharmacol., 2001; 76(2): 139-43.
16. Takemoto DJ. "Purification and characterization of a cytostatic factor with anti-viral activity from the bitter melon." Prep Biochem., 1983; 13(4): 371-93.
17. Omoregbe RE, Ikuebe OM, Ihimire IG "Antimicrobial activity of some medicinal plants' extracts on Escherichia coli, Salmonella paratyphi and Shigella dysenteriae." Afr J Med Med Sci., 1996; 25(4): 373-75.
18. Khan MR., Omoloso AD. Khan, MR. "Momordica charantia and Allium sativum: Broad spectrum antibacterial activity." Korean J Pharmacol., 1998; 29(3): 155-58.
19. Ono H, Tesaki S, Tanabe S, Watanabe M. 6-methylsulfinylhexyl isothiocyanate and its homologues as food-originated compounds with antibacterial activity against Escherichia coli and Staphylococcus aureus. Biosci Biotech Biochem., 1998; 62(2): 363-365.
20. Sankaranarayanan J, Jolly CI. Phytochemical, antibacterial and pharmacological investigations on Momordica charantia Linn., Emblica officinalis gaertn and Curcuma longa Linn. Indian J Pharm Sci., 1993; 55 (1): 6-13.
21. Fu MH, Chen JH, Zhuang DH. Momordica charantia extract; antioxidant, antibacterial, and antihyperglycemic properties. Shipin Kexue (Beijing), 2001; 22 (4): 88-90.
22. Anwar Z, Ayub N, Khan AG. Antibacterial ability of extracts from Arbuscular mycorrhizal roots of Allium sativum L. and Momordica charantia. Hamdard Med., 2000; 43(1): 29-33
23. Newton SM, Lau C, Gurcha SS, Besra GS, Wright CW. The evaluation of forty-three plant species for in vitro antimycobacterial activities; isolation of active constituents from Psoralea corylifolia and Sanguinaria canadensis. J Ethnopharmacol., 2002; 79 (1): 57-67.
24. Cheesbrough M. Medical laboratory Manual for Tropical Countries, Vol. II Butterworth-Heinemann Limited, 1984; 33-47: 16-391.
25. th ed. NCCLS document M2-A7, Wayne, PA.
26. Oliff HS. American Botanical Council: Monograph. Momordica charantia (Bitter melon). Alt Med Rev. 2007; 12(4):360-363. www.herbagram.org
27. Kohlert, C., I. van Rensen, R. März, G. Schindler, E. U. Graefe, and M. Veit.. Biovailability and pharmacokinetics of natural volatile terpenes in animals and humans. Planta Med., 2000; 66:495-505.
28. Trombetta D, Castelli F, Sarpietro M G, Venuti V, et al. Mechanisms of Antibacterial Action of Three Monoterpenes. Antimicrob Agents Chemother., 2005; 49(6): 2474-2478.
29. nd Edition. Lange Medical Publications, CA. 1984. Chap. 2; 9-22.
30. th Edition. Blackwell Scientific Publications. 1992; Chapt. 12: 258-287
31. Bhakuni DS, Dhar ML, Dhar MM, Dhawan BN, et al. "Screening of Indian plants for biological activity: Part XIII." Indian J Exp Biol., 1988; 26(11): 883RY-904.
32. CDC NNIS System. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1990-May 1999. Am J Infect Control 1999; 27:520-532.
33. Hussain HSN, Deen YY. "Plants in Kano ethomedicine: Screening for antimicrobial activity and alkaloids." Int J Pharmacol., 1992; 29(1): 51-6.
34. Yesilada E, Gurbuz I, Shibata H. "Screening of Turkish antiulcerogenic folk remedies for anti-Helicobacter pylori activity." J Ethnopharmacol., 1999; 66(3): 289-93.
35. Terenzi A, Bolognesia A, Pasqualucci L. et al. "Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumor